- The stock price of Acutus Medical Inc (NASDAQ: AFIB) fell by over 10% intraday today. This is why.
The stock price of Acutus Medical Inc (NASDAQ: AFIB) fell by over 10% intraday today. This is why.
Why: Q4 results
Q4 results: Acutus Medical reported a Q4 EPS of ($0.63), which was $0.05 higher than a consensus of ($0.68). And the revenue for the quarter was $5 million compared to a consensus of $4.43 million.
Guidance: Acutus Medical estimated an FY 2023 revenue range of $18 million to $21 million compared to a consensus of $20.597 million.
KEY QUOTE:
“Our fourth quarter results demonstrated significant progress on our strategic and financial objectives, as we achieved our highest level of quarterly sales on record while also registering our lowest level of cash burn and operating expenses since IPO. As we enter 2023, our focus turns from stabilization to growth through increased adoption of our differentiated mapping and therapy platform, and geographic expansion as well as continued improvement in our financial profile.”
- David Roman, President & CEO of Acutus
